July 10, 2012 — New and updated evidence-based guidelines to help healthcare providers choose the most appropriate medical imaging exam or radiation therapy for a patient’s clinical condition are now available via the latest version of the American College of Radiology (ACR) Appropriateness Criteria. These continually updated criteria are a national standard, developed by expert panels of physicians from many different medical specialties.

In the latest version, the ACR updated 39 appropriateness criteria topics and added five new criteria — breast cancer screening, radiologic management of gastric varices, imaging of mesenteric ischemia, definitive therapy for early-stage cervical cancer and radiation therapy for small-cell lung cancer. ACR Appropriateness Criteria guide physicians when ordering exams and help ensure that patients get the right scan or therapy for the right indication. The criteria have also been shown to improve quality, reduce unnecessary exams and lower costs.

“In today’s society, evidence-based medicine is critical for the optimal management of cancer patients. Use of ACR Appropriateness Criteria allows physicians to educate themselves regarding the latest evidence-based approach for a wide variety of therapeutic decisions to provide the best care for their patients with cancer,” said Benjamin Movsas, M.D., FACR, chair of the ACR Committee on Radiation Oncology Appropriateness Criteria.

ACR Appropriateness Criteria provide a tool for more effective clinical decision-making and to help ensure that imaging is neither over- nor under-utilized. The criteria include topics from more than 350 expert panelists in breast, cardiac, gastrointestinal, musculoskeletal, neurologic, thoracic, urologic, pediatric, vascular and women’s imaging, as well as interventional radiology and radiation oncology. There are 180 topics with over 850 variants available.

“ACR Appropriateness Criteria can help providers identify when they can replace an exam that uses ionizing radiation with one that does not, or even when no imaging exam may be needed at all. This can reduce patient and population exposure to radiation and ensure appropriate imaging, without disrupting the doctor-patient relationship or delaying needed care,” said E. Kent Yucel, M.D., FACR, chair of the ACR Committee on Diagnostic Imaging and Interventional Radiology Appropriateness Criteria.

For more information: http://www.acr.org/Quality-Safety/Appropriateness-Criteria


Related Content

News | PET-CT

June 19, 2025 — Building on a collaboration that spans more than three decades, GE HealthCare has renewed its research ...

Time June 19, 2025
arrow
News | Imaging Software Development

June 12, 2025 — GE HealthCare has announced the combination of GE HealthCare’s proprietary features and algorithms with ...

Time June 12, 2025
arrow
News | Radiology Business

The issue of sustainability in healthcare has gained increasing focus over the past several years. During a 2022 plenary ...

Time May 06, 2025
arrow
News | Cardiac Imaging

April 30, 2025 – Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, has launched Viz ...

Time May 02, 2025
arrow
News | Lung Imaging

April, 15, 2025 — Optellum has entered an agreement with Bristol Myers Squibb to leverage AI in early diagnosis and ...

Time April 17, 2025
arrow
News | Pediatric Imaging

April 10, 2025 — Cincinnati Children’s and GE HealthCare will form a strategic research program focused on driving ...

Time April 10, 2025
arrow
News | X-Ray

March 18, 2025 — GE HealthCare recently announced a collaboration with NVIDIA expanding the existing relationship ...

Time March 19, 2025
arrow
News | Artificial Intelligence

March 10, 2025 — Lunit, a provider of AI-powered solutions for cancer diagnostics and therapeutics, has published a ...

Time March 10, 2025
arrow
News | SPECT Imaging

Feb. 5, 2025 — Serac Healthcare Ltd., a clinical radiopharmaceutical company developing an innovative molecular imaging ...

Time February 05, 2025
arrow
News | Computed Tomography (CT)

Dec. 3, 2024 — During RSNA '24, GE HealthCare announced the 510(k) submission to the U.S. Food and Drug Administration ...

Time December 18, 2024
arrow
Subscribe Now